Animal studies have shown that a deficiency in brain of the n-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA) is associated with memory loss and diminished cognitive function. The senescence-accelerated prone 8 (SAMP8) mouse develops impairments in learning and memory at 8-12 months of age. The effect of diet supplemented with n-3 PUFA on brain phospholipid DHA status, learning, and memory ability in aged SAMP8 mice was investigated. At the age of 10 months, SAMP8 mice were fed either a low-DHA or a high-DHA diet for 8 weeks. In comparison to SAMP8 mice fed the low-DHA diet, those fed a high-DHA diet had improved acquisition and retention in a T-maze foot shock avoidance test and a higher proportion of DHA in hippocampal and amygdala phospholipids. This study demonstrates that, in mature animals, DHA is incorporated into brain phospholipids and that dietary n-3 PUFA is associated with delay in cognitive decline.Key Words: Alzheimer's disease-n-3 Polyunsaturated fatty acids-Docosahexaenoic acid-Hippocampus-Memory.
BRAIN tissue membrane phospholipids (PL) are rich in the n-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid . It has been shown that the balance between DHA and the n-6 PUFA arachidonic acid (20:4n-6) in brain membrane PL is crucial for normal functioning of the central nervous system (1-5). Humans and animals must obtain essential n-3 PUFA and n-6 PUFA from their diet. The sources for DHA and 20:4n-6 in brain membrane PL are derived from the diet or from conversion of their respective dietary precursors in liver (6,7). The precursors of DHA are a-linolenic acid from plant products and eicosapentaenoic acid (EPA or 20:5n-3) of marine origin and that of 20:4n-6 is linoleic acid (18:2n-6).Studies demonstrate that lipid peroxidation in brain is an early event in Alzheimer's disease (AD), which strengthens the hypothesis that oxidative damage may play a role in the pathogenesis of AD (8,9). The double bonds in PUFA are highly susceptible to peroxidative damage, which is initiated by reactive oxygen species (10) and results in a decrease in content of n-6 PUFA and n-3 PUFA in membrane PL. Decrease in the DHA content of hippocampal tissue during aging has been demonstrated in patients with AD (11) and in 12-month-old senescence-accelerated prone 8 (SAMP8) mice (12). The SAMP8 strain of mice is a model of AD, because the mice develop age-related deficits in learning and memory that is associated with an age-related overexpression of amyloid precursor protein (APP) and elevated levels of amyloid-beta (Ab) protein in brain (13-18). According to the amyloid hypothesis, accumulation of Ab protein is central to the pathogenesis of . It has been suggested that DHA is a possible therapeutic agent for ameliorating learning deficiencies caused by AD, which could act by suppressing the increases in the levels of lipid peroxide, reactive oxygen species, and amyloid accumulation in AD models (22)(23)(24).Epidemiological (25)(26)(27) and animal studies (28-31) have reported that there is an associati...